These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3299016)

  • 1. Effects of MK-733 on plasma lipid and lipoprotein levels in subjects with hypercholesterolaemia.
    Simons LA; Nestel PJ; Calvert GD; Jennings GL
    Med J Aust; 1987 Jul; 147(2):65-8. PubMed ID: 3299016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
    Simons LA; Simons J; Parfitt A
    Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
    Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Leuven JA; Schouten JA; Stalenhoef AF
    Lancet; 1986 Oct; 2(8513):936-9. PubMed ID: 2877129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.
    Mölgaard J; von Schenck H; Olsson AG
    Eur Heart J; 1988 May; 9(5):541-51. PubMed ID: 3402470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).
    Simons LA
    Aust N Z J Med; 1998 Jun; 28(3):327-33. PubMed ID: 9673745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
    Simons LA; Nestel PJ; Clifton P; Janus ED; Simons J; Parfitt A
    Med J Aust; 1992 Nov; 157(9):584-9. PubMed ID: 1406416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an ethyl ester preparation of fish oils (Himega) on lipids and lipoproteins in hyperlipidaemia.
    Simons LA; Parfitt A; Simons J; Balasubramaniam S
    Aust N Z J Med; 1990 Oct; 20(5):689-94. PubMed ID: 2285385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
    Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA; Hickie JB; Balasubramaniam S
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
    Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.
    Hunninghake DB; Knopp RH; Schonfeld G; Goldberg AC; Brown WV; Schaefer EJ; Margolis S; Dobs AS; Mellies MJ; Insull W
    Atherosclerosis; 1990 Nov; 85(1):81-9. PubMed ID: 2126437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
    Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
    Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjects.
    Decochez K; Rippley RK; Miller JL; De Smet M; Yan KX; Matthijs Z; Riffel KA; Song H; Zhu H; Maynor HO; Tanaka W; Johnson-Levonas AO; Davies MJ; Gottesdiener KM; Keymeulen B; Wagner JA
    Drugs R D; 2006; 7(2):99-110. PubMed ID: 16542056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.